By Theresa Gaffney , Nov. 11, 2025
The FDA announced yesterday that it had reversed a 2003 decision to put a stringent warning on hormone therapy products for menopausal women. The warning will be removed from products like a patch or pill
where the hormones are absorbed throughout the body, as well as localized therapies like a topical cream or ring.
Many physicians, as well as the American College of Obstetricians and Gynecologists, have long advocated for the “black box” warning to be removed from local hormone therapies in particular. But some people have expressed concerns about the way that the Trump administration went about making the change, while others worried about how the administration described the existing data. “[Makary’s] claim that hormones for menopause is the best way to improve the health of women sounds like a PR statement, not a scientific one,” Diana Zuckerman, who leads the nonprofit think tank the National Center for Health Research, told STAT after the announcement.
Read the entire article on the details of the announcement and how
experts reacted.